Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| NUVL | Flynn James E | Director | 15.07.2026 | Abgabe | 124,00 | 3.444 | 427.056 | Form 4 |
| NUVL | Flynn James E | Director | 15.07.2026 | U | 124,00 | 5.146 | 638.104 | Form 4 |
| NUVL | Flynn James E | Director | 15.07.2026 | Abgabe | 124,00 | 650.000 | 80.600.000 | Form 4 |
| NUVL | Flynn James E | Director | 15.07.2026 | Abgabe | 124,00 | 8.299.225 | 1.029.103.900 | Form 4 |
| NUVL | Meyers Michael L. | Director | 15.07.2026 | Abgabe | — | 3.444 | — | Form 4 |
| NUVL | Meyers Michael L. | Director | 15.07.2026 | U | 124,00 | 5.146 | 638.104 | Form 4 |
| NUVL | Balcom Alexandra | Chief Financial Officer | 15.07.2026 | Abgabe | — | 14.350 | — | Form 4 |
| NUVL | Balcom Alexandra | Chief Financial Officer | 15.07.2026 | Zuteilung | — | 14.350 | — | Form 4 |
| NUVL | Balcom Alexandra | Chief Financial Officer | 15.07.2026 | Abgabe | — | 41.100 | — | Form 4 |
| NUVL | Balcom Alexandra | Chief Financial Officer | 15.07.2026 | U | 124,00 | 44.433 | 5.509.692 | Form 4 |
| NUVL | Srivastava Sapna | Director | 15.07.2026 | Abgabe | — | 3.444 | — | Form 4 |
| NUVL | Srivastava Sapna | Director | 15.07.2026 | U | 124,00 | 5.146 | 638.104 | Form 4 |
| NUVL | Oliger Christy J. | Director | 15.07.2026 | Abgabe | — | 6.091 | — | Form 4 |
| NUVL | Oliger Christy J. | Director | 15.07.2026 | U | 124,00 | 1.324 | 164.176 | Form 4 |
| NUVL | Squarer Ron | Director | 15.07.2026 | Abgabe | — | 6.281 | — | Form 4 |
| NUVL | Turner Christopher Durant | Chief Medical Officer | 15.07.2026 | Abgabe | — | 14.350 | — | Form 4 |
| NUVL | Turner Christopher Durant | Chief Medical Officer | 15.07.2026 | Zuteilung | — | 14.350 | — | Form 4 |
| NUVL | Turner Christopher Durant | Chief Medical Officer | 15.07.2026 | Abgabe | — | 41.100 | — | Form 4 |
| NUVL | Turner Christopher Durant | Chief Medical Officer | 15.07.2026 | U | 124,00 | 31.530 | 3.909.720 | Form 4 |
| NUVL | Noci Darlene | Chief Development Officer | 15.07.2026 | Abgabe | — | 14.350 | — | Form 4 |
| NUVL | Noci Darlene | Chief Development Officer | 15.07.2026 | Zuteilung | — | 14.350 | — | Form 4 |
| NUVL | Noci Darlene | Chief Development Officer | 15.07.2026 | Abgabe | — | 41.100 | — | Form 4 |
| NUVL | Noci Darlene | Chief Development Officer | 15.07.2026 | U | 124,00 | 17.017 | 2.110.108 | Form 4 |
| NUVL | Lane Benjamin | See Remarks | 15.07.2026 | Abgabe | — | 7.120 | — | Form 4 |
| NUVL | Lane Benjamin | See Remarks | 15.07.2026 | Zuteilung | — | 7.120 | — | Form 4 |
| NUVL | Lane Benjamin | See Remarks | 15.07.2026 | Abgabe | — | 29.433 | — | Form 4 |
| NUVL | Lane Benjamin | See Remarks | 15.07.2026 | U | 124,00 | 21.092 | 2.615.408 | Form 4 |
| NUVL | Pelish Henry E. | Chief Scientific Officer | 15.07.2026 | Abgabe | — | 14.350 | — | Form 4 |
| NUVL | Pelish Henry E. | Chief Scientific Officer | 15.07.2026 | Zuteilung | — | 14.350 | — | Form 4 |
| NUVL | Pelish Henry E. | Chief Scientific Officer | 15.07.2026 | Abgabe | — | 41.100 | — | Form 4 |
| NUVL | Pelish Henry E. | Chief Scientific Officer | 15.07.2026 | U | 124,00 | 22.393 | 2.776.732 | Form 4 |
| NUVL | Porter James Richard | President and CEO | 15.07.2026 | Abgabe | — | 40.025 | — | Form 4 |
| NUVL | Porter James Richard | President and CEO | 15.07.2026 | Zuteilung | — | 40.025 | — | Form 4 |
| NUVL | Porter James Richard | President and CEO | 15.07.2026 | Abgabe | — | 121.350 | — | Form 4 |
| NUVL | Porter James Richard | President and CEO | 15.07.2026 | U | 124,00 | 203.529 | 25.237.596 | Form 4 |
| NUVL | Miller Deborah Ann | Chief Legal Officer | 15.07.2026 | Abgabe | — | 14.350 | — | Form 4 |
| NUVL | Miller Deborah Ann | Chief Legal Officer | 15.07.2026 | Zuteilung | — | 14.350 | — | Form 4 |
| NUVL | Miller Deborah Ann | Chief Legal Officer | 15.07.2026 | Abgabe | — | 41.100 | — | Form 4 |
| NUVL | Miller Deborah Ann | Chief Legal Officer | 15.07.2026 | U | 124,00 | 18.534 | 2.298.216 | Form 4 |
| NUVL | Protopapas Anna | Director | 15.07.2026 | Abgabe | — | 3.444 | — | Form 4 |
| NUVL | Protopapas Anna | Director | 15.07.2026 | U | 124,00 | 5.146 | 638.104 | Form 4 |
| NUVL | Bogle Grant C. | Director | 15.07.2026 | Abgabe | — | 5.577 | — | Form 4 |
| NUVL | Bogle Grant C. | Director | 15.07.2026 | U | 124,00 | 3.714 | 460.536 | Form 4 |
| NUVL | Wheeler Cameron | Director | 15.07.2026 | Abgabe | — | 3.444 | — | Form 4 |
| NUVL | Wheeler Cameron | Director | 15.07.2026 | U | 124,00 | 5.146 | 638.104 | Form 4 |
| NUVL | Porter James Richard | President and CEO | 06.07.2026 | Verkauf | 123,72 | 30.000 | 3.711.600 | Form 4 |
| NUVL | Porter James Richard | President and CEO | 06.07.2026 | Optionsausübung | 18,93 | 30.000 | 567.900 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).